We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Christopher Spurney

Christopher Spurney MD, FAHA

Professor of Pediatrics, Children’s National Health System, Washington, DC

Dr. Spurney is a Professor of Pediatrics at Children’s National Health System in Washington, DC. He completed his undergraduate studies at Cornell University College of Arts and Sciences and attended New York Medical College. He completed his pediatrics residency at New York-Presbyterian Hospital  and pediatric cardiology fellowship at Children’s National Medical Center. He joined the faculty of Children’s National Medical Center in 2004 and was awarded the National Institute of Child Health and Human Development Child Health Research Career Development Award. His research focuses on the cardiomyopathy related to muscular dystrophies. He obtained research funding from the National Institutes of Health, the Muscular Dystrophy Association and a number of muscular dystrophy related foundations. He has over 50 peer reviewed publications and has lectured internationally on dystrophic cardiomyopathy. He is an attending physician in the echocardiography lab and inpatient services at Children’s National.  He enjoys mentoring fellows and is the Associate Cardiology Fellowship Program Director. He was named Fellow of the American Heart Association in 2017.

Disclosures

Dr. Spurney reports the following disclosures: 3 consultancy agreements relating to DMD cardiomyopathy, with Bayer, Astellas and ReveraGen.

Recent Contributions to PracticeUpdate:

  1. Genetic Basis of Severe Childhood-Onset Cardiomyopathies